Unresectable metastatic liver disease: New therapeutical alternatives

Hepato-Gastroenterology

Volumn 46, Issue SUPPL. 1, 1999, Pages 1297-1305

  Lygidakis, N J ^a,b  

^a ATHENS MEDICAL CENTER   (Greece)

^b NONE   (Greece)

Author keywords

Colorectal origin; Life expectancy; Locoregional immunochemotherapy; Secondary liver tumors

Indexed keywords

IODINATED POPPYSEED OIL; MEGLUMINE DIATRIZOATE; RECOMBINANT INTERLEUKIN 2;

ADULT; AGED; CANCER SURVIVAL; CONFERENCE PAPER; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOSTIMULATION; IMMUNOTHERAPY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOPHENOTYPING; INJECTIONS, INTRA-ARTERIAL; INTERLEUKIN-2; LIVER NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033049770     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Lygidakis NJ, Thodorakopoulou M, Dedemadi G, Spentzouris N, Kyriakou A, Gemos K, Kekic S, Protopsaltis J, Pearl A: Resection of unresectable secondary liver tumors - new frontiers in liver surgery. Hepato-Gastroenterol 1997; 44:1632-16-40.
2. Lygidakis NJ, et al: Resection of unresectable liver tumors: New frontiers in liver surgery. Hepato-Gastroenterol 1997; 44:1632-1640.
3. Nuzzo G, et al: Resection of hepatic metastases from colorectal cancer. Hepato-Gastroenterol 1997; 44:199-204.
4. Okuno K, et al: Interleukin 12 augments the liver associated immunity and reduces liver metastases. Hepato-Gastroenterol 1996; 43:1196-1202.
5. Hiei K, et al: Resection of metastatic liver cancer in a patient with an anomalous intrahepatic portal system. A case report. Hepato-Gastroenterol 1995; 42:1002-1007.
6. Kotanagi H, et al: Blood vessel invasion in metastatic nodes for development of liver metastases in colorectal cancer. Hepato-Gastroenterol 1996; 43:771-774.
7. Taniguchi H, et al: Comparison of survival between hepatic metastasis of gastric and colorectal cancer. Hepato-Gastroenterol 1996; 43:897-900.
8. Battista SG, et al: Factors influencing incidence and extension of metachronous liver metastases of colorectal adenocarcinoma: A multivariate analysis. Hepato-Gastroenterol 1997; 44:1057-1062.
9. Okuno K, et al: Adjuvant hepatic arterial IL2, MMC and 5-FLT after curative resection of colorectal liver metastasis. Hepato-Gastrocnterol 1996; 43:688-691.
10. Ishikawa O: Regional chemotherapy to prevent hepatic metastasis after resection of pancreatic cancer. Hepato-Gastroenterol 1997; 44:1541-1546.
11. Lygidakis NJ, et al: Unresectable pancreatic cancer. Is a multimodality approach a promising therapeutical alternative? Hepato-Gastroenterol 1997; 44:1222-1228.
12. Lygidakis NJ, et al: Pancreatic surgery today. Hepato-Gastroenterol 1996; 43:779-784.
13. Lygidakis NJ, et al: Multidisciplinary management of hcpatocellular carcinoma. Hepato-Gastroentevol 1997; 44:1611-1619.
14. Lygidakis NJ: Adjuvant therapy following pancreatic resection for pancreatic duct carcinoma: a prospective randomized study. Hepato-Gastrounlerol 1996; 43:671-680.
15. Gazzaniga GM, Ciferri E, Fazio S, Bagarolo C, et al: Repeated hepatic resections for recurrent metastasis of colorectal cancer, Hepato-Gastroenterol 1995; 42:383-386.
16. Lygidakis NJ: A new look in the management of unresectable primary hepatocellular carcinoma. Hepato-Gastroenterol 1992; 39:577-583.
17. Hamazaki K, Yogi T, Inagaki M, Tanaka N, Mimura H, Orita K, Lygidakis NJ: Hepatectomy with extracorporeal circulation for liver metastasis from colon carcinoma located at the confluence of the major hepatic vein: A case report. Hepato-Gastroenterol 1994; 41:150-153.
18. Zieren HU, Mueller JM, Zieren S: Resection of colorectal liver metastasis in old patients. Hepato-Gastroenterol 1994; 41:34-37.
19. Kemeny M: Regional chemotherapy for liver metastasis from colorectal cancer. Hepato-Gastroenterol 1992; 40:18-23.
20. Oka M, Hazama S, Suzuki M, Ogura Y, Kobayashi N, Suzuki T: Histological analysis of hepatocellular carcinoma treated by intraarterial combined immuno-chemotherapy. Hepato-Gastroenterol 1995; 42:561-562.
21. Yamamoto M, Fujii H: Optimal locoregional immunochemotherapy after tumor-mass reduction for advanced hepatocellular carcinoma. Hepato-Gastroenterol 1995; 42:567-577.
22. Okuno K, Yasutomi M: Locoregional immunochemotherapy in liver carcinoma - present and future. Hepato-Gastroenterol 1995; 42:578-586.
23. Lygidakis NJ: Pancreatic head carcinoma: Is pancreatic resection indicated for patients with stage III pancreatic duct cancer? Hepato-Gastroenterol 1995; 42:587-596.
24. Lygidakis NJ, Berberabe AE, Spentzouris N, Dedemadi G, Kalligas T, Loukas G, Sotiropoulou P: Targeting locoregional immunochemotherapy with new drugs in metastatio liver disease: A promising alternative. Hepato-Gastroenterol 1998; 45:2248-2251.
25. Lygidakis NJ, Stringaris K: Locoregional chemoimmunotherapy transplenic and transtumoral in vivo immunostimulation. Hepato-Gastroenterol 1996; 43:440-447.
26. Lygidakis NJ, Ziras N, Parissis J: Resection versus resection combined with adjuvant pre- and postoperative chemotherapy-immunotherapy for melastatic colorectal liver cancer. A new look at an old problem. Hepato-Gastroenterol 1995; 42(2):155-161.
27. Lygidakis NJ, Safioleas M, Sgourakis G, Spentzouris N, Dedemadi G, Sotiropoulou P: Metastatic Melanoma: Transplenic Immunostimulation - A New Therapeutical Alternative for an over-challenging Disease. Hepato-Gastroenterol 1999; 46:148-156.
28. Lygidakis NJ, Spentzouris N, Thodorakopoulou M, Dedemadi G, Gemos K, Kyriakou A: Pancreatic resection for pancreatic carcinoma combined with neo- and adjuvant locoregional targeting immuno-chemotherapy -Aprospective randomized study. Hepato-Gastroenterol 1998; 45(20):396-403.
29. Lygidakis NJ, Tsiliakos S, Talaat A, Matsakis G, Tepetes K: Multidisciplinary management of hepatocellular carcinoma. Hepato-Gastroenterol 1997; 44(13):268-273.
30. Lygidakis NJ, Pearl A: Metastatic liver disease - A review. Hepato-Gastroenterol 1997; 44:1484-1487.
31. Lygidakis NJ, Savanis G, Touloupakis E, Katsikoyiannis N, Kapetanakis A, Pothoulakis J, Maganas D, Papadimitrous A, Batziotis N, Zisimopoulos A, Geronikola-Trapeli X: Induced in vivo targeted transarterial and transvenous immunostimulation in patients with unresectable pancreatic carcinoma. Hepato-Gastroenterol 1993; 40:574-581.
32. Lygidakis NJ, Berberabe AE, Spentzouris N, Dedemadi G, Kalligas T, Loukas G, Sotiropoulou V: A prospective randomized study using adjuvant locoregional chemoimmunotherapy in combination with surgery for pancreatic carcinoma. Hepato-Gastroenterol 1998; 45:2376-2381.
33. Bhattacharya S, Novel SR, Winslet MS, Hobbs KEF: Iodized oil in the treatment of hepatocellular carcinoma. Br J Surg 1994; 81:1563-1571.
34. Lygidakis NJ, Spentzouris N, Dedemadi G: Resectional liver surgery in metastalic liver disease, Hepato-Gastrocntorol 1998; 45(22):1034-1038.
35. Lygidakis NJ, Stringaris K, Kokinis K, Lyberopoulos K, Raptis S: Locoregional chemotherapy versus locoregional combined immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomized study. Hepato-Gastroenterol 1996; 43(7):212-220.
36. Genmari L: Liver metastases: a many sided therapeutic problem. Hepato-Gastroenterol 1992; 39:5-9.
37. Lygidakis NJ, Spentzouris N, Dedemadi G, Kyriakou A, Theodorakopoulos M: Intrasplenic immunostimulation in malignancies. Fact or fiction? Present and future. Hepato-Gastroenterol 1998; 45:404-410.
38. Kemeny MM, Goldberg D, Beaty D, Blayney D, Browning S: Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 1986; 64:492-496.
39. Rougier P, et al: A controlled multicenter trial of intrahepatic: chemotherapy vs. standard palliative treatment for colorectal liver metastases. Proc Am Soc Clin Oncology 1990; pp. 9-104.